ArticleFoods (Basel, Switzerland)2026
Valorization of Beetroot Pomace as a Flour Fortifier, Functional Ingredient and Dietary Supplement.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The aim of this study was to evaluate the potential of minimally processed beetroot pomace (BP), obtained from an industrial juice producer selected as a case study, converted into a stable beetroot pomace flour (BPF) at an industrial scale level, for flour fortification, functional confectionery development, and dietary supplementation. It was characterized by a high dietary fiber content (~27 g/100 g) and a very low carbohydrate-to-fiber ratio (1.9). High level of total phenolics and flavonoids (14.1 ± 0.1 mg GAE/g and 1.43 ± 0.1 mg QE/g), betacyanins and betaxanthins (898 ± 54 and 960 ± 65 µg/g), as well as pronounced antioxidant (FRAP 31.5 ± 1.1 and DPPH 25.8 ± 2.9 µmol TE/g), anti-hyperglycemic and anti-inflammatory activity (27.3 ± 1.3% and 41.0 ± 3.4%) remained upon in vitro digestion. Replacing 14-28% of cereal and pseudo-cereal flour with BPF reduced the carbohydrate-to-fiber ratio to the recommended 10:1, while incorporation of 20% BPF into cookies reduced this ratio by 2.5-fold and the glycemic index from ~56 to ~30. Furthermore, long-term supplementation of standard and high-fat/high-sucrose diet with BPF (0.5%
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.